ASCO 2024 Round Up: Advancements in Biomarker-Driven Medicines, Cancer Vaccines, and AI Applications Paving the Way for Expansion of Precision Oncology
Frost & Sullivan
JUNE 24, 2024
Biomarker Driven Treatments for Lung Cancers Continue to Gain Prominence The impetus in the field of lung cancer research is sustained by the emergence of new data, which showcased the encouraging clinical outcomes presented by major biopharmaceutical companies.
52 
Let's personalize your content